WHO recommends an integrase inhibitor as preferred HIV treatment option in all populations
El dolutegravir es un medicamento nuevo, más potente, asequible, con menos posibilidades ...
Gender perspective in HIV
A recent study shows differences in quality of life related to health among people with HI ...
